| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 49 companies in the Life Sciences Tools & Services industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 5, 2025 | NTRA Natera, Inc. | Chapman Steven Leonard56 | CEO And President | Sell | 87,272 | $143.40 | $12,515,005.94 | -7.1% | +8.3% | +33.2% | |
| Mar 5, 2025 | NTRA Natera, Inc. | Moshkevich Solomon | President, Clinicaldiagnostics | Sell | 6,000 | $143.29 | $859,734.20 | -1.0% | +8.3% | +33.2% | |
| Mar 5, 2025 | GRAL Grail, Inc. | Ragusa Robert P | Chief Executive Officer | Sell | 994 | $41.51 | $41,260.94 | -0.1% | +0.7% | +35.2% | |
| Mar 5, 2025 | FLGT Fulgent Genetics, Inc. | Kim Paul77 | CFO And Treasurer | Buy | 100,000 | $15.96 | $1,596,470.00 | +40.3% | +27.1% | -14.4% | |
| Mar 5, 2025 | TMO Thermo Fisher Scientific Inc. | Casper Marc N59 | Chairman &CEO | Sell | 18,000 | $518.16 | $9,326,854.17 | -0.9% | -23.7% | -1.0% | |
| Mar 4, 2025 | CSTL Castle Biosciences Inc | Maetzold Derek J69 | Pres. &Chief Exec. Officer | Sell | 5,687 | $20.86 | $118,619.45 | -2.2% | -26.8% | +26.7% | |
| Mar 4, 2025 | VCYT Veracyte, Inc. | Febbo Phillip G.63 | Chief Scientific &Med Officer | Sell | 8,037 | $33.35 | $268,012.94 | -4.5% | -21.6% | +6.3% | |
| Mar 4, 2025 | VCYT Veracyte, Inc. | Stapley Marc60 | Chief Executive Officer | Sell | 52,697 | $33.34 | $1,756,855.23 | -6.0% | -21.6% | +6.3% | |
| Mar 4, 2025 | VCYT Veracyte, Inc. | McGuire Annie46 | SVP, General Counsel | Sell | 1,142 | $33.69 | $38,476.49 | -1.6% | -21.6% | +6.3% | |
| Mar 3, 2025 | GH Guardant Health, Inc. | Joyce Meghan V.56 | Director | Sell | 100 | $42.71 | $4,271.00 | -1.3% | +3.3% | +129.0% | |
| Mar 3, 2025 | WGS Genedx Holdings Corp. | Feeley Kevin46 | Chief Financial Officer | Sell | 261 | $103.94 | $27,128.34 | -6.3% | -21.4% | -18.4% | |
| Mar 3, 2025 | TMO Thermo Fisher Scientific Inc. | Shafer Michael D65 | Executive Vice President | Sell | 1,780 | $530.92 | $945,037.60 | -8.5% | -24.3% | -3.0% | |
| Feb 28, 2025 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 67,434 | $1.71 | $115,312.14 | - | -21.8% | -31.0% | |
| Feb 27, 2025 | MEDP Medpace Holdings, Inc. | Ewald Stephen P59 | General Counsel &Corp. Secy. | Buy | 2 | $326.11 | $652.22 | - | -9.9% | +38.5% | |
| Feb 27, 2025 | VCYT Veracyte, Inc. | Leite John49 | Chief Commercial Officer-clia | Sell | 5,746 | $33.84 | $194,444.64 | -6.8% | -21.0% | +8.0% | |
| Feb 26, 2025 | NTRA Natera, Inc. | Sheena Jonathan46 | Director, Co-founder | Sell | 5,700 | $160.50 | $914,873.49 | -0.3% | -2.1% | +34.6% | |
| Feb 24, 2025 | MTD Mettler Toledo International Inc/ | Magloth Christian66 | Head Of Human Resources | Sell | 790 | $1,313.69 | $1,037,815.10 | -51.8% | -11.2% | +5.3% | |
| Feb 24, 2025 | TMO Thermo Fisher Scientific Inc. | Lowery Frederick M.65 | Executive Vice President | Sell | 18,300 | $531.81 | $9,732,123.00 | -51.9% | -24.6% | -3.7% | |
| Feb 24, 2025 | MEDP Medpace Holdings, Inc. | Carley Brian T | Director | Sell | 4,003 | $345.59 | $1,383,396.77 | -13.3% | -13.3% | +28.5% | |
| Feb 24, 2025 | TWST Twist Bioscience Corp | Werner Robert F.62 | Chief Accounting Officer | Sell | 1,183 | $42.27 | $50,004.37 | -1.1% | -28.5% | +17.9% | |
| Feb 21, 2025 | TWST Twist Bioscience Corp | Cho Dennis70 | See Remarks | Sell | 526 | $44.18 | $23,237.10 | -0.5% | -31.8% | +17.6% | |
| Feb 21, 2025 | TWST Twist Bioscience Corp | Leproust Emily M.77 | Chief Executive Officer | Sell | 2,790 | $44.18 | $123,253.83 | -0.4% | -31.8% | +17.6% | |
| Feb 21, 2025 | TWST Twist Bioscience Corp | Green Paula69 | SVP Of Human Resources | Sell | 618 | $44.18 | $27,301.39 | -0.5% | -31.8% | +17.6% | |
| Feb 21, 2025 | TWST Twist Bioscience Corp | Laponis Adam58 | Chief Financial Officer | Sell | 918 | $44.18 | $40,554.49 | -0.8% | -31.8% | +17.6% | |
| Feb 21, 2025 | TWST Twist Bioscience Corp | Finn Patrick John73 | President And COO | Sell | 1,839 | $44.18 | $81,241.50 | -0.7% | -31.8% | +17.6% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.